![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | RGD:1317511 | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of MRPS18C mRNA | CTD | PMID:24763279 | 1,2-dichloroethane | increases expression | ISO | RGD:1317512 | 6480464 | ethylene dichloride results in increased expression of MRPS18C mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1317512 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of MRPS18C mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1317512 | 6480464 | Ethinyl Estradiol affects the expression of MRPS18C mRNA | CTD | PMID:17555576 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MRPS18C mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317512 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPS18C mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPS18C mRNA | CTD | PMID:32109520 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1317511 | 6480464 | Lactic Acid results in decreased expression of MRPS18C mRNA | CTD | PMID:30851411 | 4-phenylbutyric acid | decreases expression | ISO | RGD:1317511 | 6480464 | 4-phenylbutyric acid results in decreased expression of MRPS18C mRNA | CTD | PMID:14583596 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of MRPS18C mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | increases expression | ISO | RGD:1317511 | 6480464 | Tretinoin results in increased expression of MRPS18C mRNA | CTD | PMID:33167477 | arsenite(3-) | multiple interactions | ISO | RGD:1317511 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to MRPS18C mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | RGD:1317512 | 6480464 | Benzo(a)pyrene results in increased expression of MRPS18C mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | RGD:1317511 | 6480464 | Benzo(a)pyrene results in increased methylation of MRPS18C promoter | CTD | PMID:27901495 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MRPS18C mRNA, [bisphenol A co-treated with Testosterone] results in decreased expression of MRPS18C mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | ISO | RGD:1317512 | 6480464 | bisphenol A results in increased expression of MRPS18C mRNA | CTD | PMID:33221593 | bisphenol A | decreases methylation | ISO | RGD:1317512 | 6480464 | bisphenol A results in decreased methylation of MRPS18C promoter | CTD | PMID:27312807 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MRPS18C mRNA | CTD | PMID:25181051 | cadmium atom | multiple interactions | ISO | RGD:1317511 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS18C mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1317511 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS18C mRNA | CTD | PMID:35301059 | cannabidiol | increases expression | ISO | RGD:1317511 | 6480464 | Cannabidiol results in increased expression of MRPS18C mRNA | CTD | PMID:27714895 | CGP 52608 | multiple interactions | ISO | RGD:1317511 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MRPS18C gene] | CTD | PMID:28238834 | crocidolite asbestos | decreases expression | ISO | RGD:1317512 | 6480464 | Asbestos, Crocidolite results in decreased expression of MRPS18C mRNA | CTD | PMID:29279043 | cylindrospermopsin | increases expression | ISO | RGD:1317511 | 6480464 | cylindrospermopsin results in increased expression of MRPS18C mRNA | CTD | PMID:24921660 | dibutyl phthalate | decreases expression | ISO | RGD:1317512 | 6480464 | Dibutyl Phthalate results in decreased expression of MRPS18C mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | ISO | RGD:1317511 | 6480464 | dicrotophos results in decreased expression of MRPS18C mRNA | CTD | PMID:28302478 | epoxiconazole | decreases expression | ISO | RGD:1317512 | 6480464 | epoxiconazole results in decreased expression of MRPS18C mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | RGD:1317512 | 6480464 | Ethanol results in increased expression of MRPS18C mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | isobutanol | multiple interactions | ISO | RGD:1317511 | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPS18C mRNA | CTD | PMID:29432896 | lead(0) | affects splicing | ISO | RGD:1317511 | 6480464 | Lead affects the splicing of MRPS18C mRNA | CTD | PMID:28903495 | lead(2+) | affects splicing | ISO | RGD:1317511 | 6480464 | Lead affects the splicing of MRPS18C mRNA | CTD | PMID:28903495 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | leflunomide | decreases expression | ISO | RGD:1317511 | 6480464 | leflunomide results in decreased expression of MRPS18C mRNA | CTD | PMID:28988120, PMID:29427785 | lipopolysaccharide | multiple interactions | ISO | RGD:1317511 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS18C mRNA | CTD | PMID:31059760 | methyl methanesulfonate | increases expression | ISO | RGD:1317511 | 6480464 | Methyl Methanesulfonate results in increased expression of MRPS18C mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | RGD:1317511 | 6480464 | methylmercuric chloride results in decreased expression of MRPS18C mRNA | CTD | PMID:28001369 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of MRPS18C mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS18C mRNA | CTD | PMID:25729387 | paracetamol | decreases expression | ISO | RGD:1317511 | 6480464 | Acetaminophen results in decreased expression of MRPS18C mRNA | CTD | PMID:31059760 | paracetamol | multiple interactions | ISO | RGD:1317511 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS18C mRNA | CTD | PMID:31059760 | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of MRPS18C mRNA | CTD | PMID:20345932 | rac-lactic acid | decreases expression | ISO | RGD:1317511 | 6480464 | Lactic Acid results in decreased expression of MRPS18C mRNA | CTD | PMID:30851411 | resveratrol | increases expression | ISO | RGD:1317512 | 6480464 | resveratrol results in increased expression of MRPS18C mRNA | CTD | PMID:22610192 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MRPS18C mRNA | CTD | PMID:25905778 | T-2 toxin | increases expression | ISO | RGD:1317511 | 6480464 | T-2 Toxin results in increased expression of MRPS18C mRNA | CTD | PMID:31863870 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of MRPS18C mRNA | CTD | PMID:26496021 | tolcapone | decreases expression | EXP | | 6480464 | tolcapone results in decreased expression of MRPS18C mRNA | CTD | PMID:24136188 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS18C mRNA | CTD | PMID:25729387 | tungsten | increases expression | ISO | RGD:1317512 | 6480464 | Tungsten results in increased expression of MRPS18C mRNA | CTD | PMID:30912803 | valproic acid | decreases methylation | ISO | RGD:1317511 | 6480464 | Valproic Acid results in decreased methylation of MRPS18C gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of MRPS18C mRNA | CTD | PMID:23034163, PMID:23555832 | |